Alignment Healthcare chairman proposes $40K sale

Konowiecki also reported a September 17, 2026 sale of 23,511 shares for gross proceeds of $202,429.71 during the prior three months.

Available on EDGAR 11/09/2026 - 05:57 PM EST Accepted by SEC EDGAR 11/09/2026 - 05:57 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) chairman / EVP, Corporate Affairs Joseph Konowiecki reported a proposed sale of 5,500 common shares, with an aggregate market value of $39,985 and an approximate sale date of November 10, 2026. The transaction is a sale-to-cover, not a discretionary trade; the actual number of shares sold will be determined by applicable tax withholding rates and the stock price at the time of sale.

Key Figures

Proposed shares for sale: 5,500 common shares Aggregate market value of proposed sale: $39,985 Common shares outstanding: 209,268,394 shares +3 more

6 metrics

Proposed shares for sale 5,500 common shares Approximate sale date November 10, 2026; the actual number sold is determined by applicable tax withholding rates and the stock price at the time of sale.

Aggregate market value of proposed sale $39,985 Proposed sale of common shares

Common shares outstanding 209,268,394 shares Securities information

Shares sold in prior three months 23,511 shares Sale on September 17, 2026

Gross proceeds from prior three-month sale $202,429.71 Sale on September 17, 2026

Shares acquired through restricted stock unit vesting 13,476 shares Acquired on November 7, 2022

Key Terms

sale-to-cover transaction, restricted stock units, tax withholding rates

3 terms

sale-to-cover transaction financial

"pursuant to a sale-to-cover transaction"

restricted stock units financial

"vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding rates financial

"applicable tax withholding rates and stock price at the time of sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALHC shares did Joseph Konowiecki report for sale?

Joseph Konowiecki reported a proposed sale of 5,500 common shares, with an aggregate market value of $39,985 and an approximate sale date of November 10, 2026.

How many shares outstanding does ALHC have?

The securities information lists 209,268,394 common shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001209523
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	8443102247
Name of Person for Whose Account the Securities are To Be Sold	Joseph Konowiecki
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chairman / EVP, Corporate Affairs

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	5500	39985	209268394	11/10/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/07/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 11/07/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			13476	11/07/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joseph Konowiecki 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	09/17/2026	23511	202429.71

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	11/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph Konowiecki
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)